Molecular target drives immunogenicity in cancer immunotherapy
Medical Xpress
March 5, 2026
Researchers at the National University of Singapore (NUS) have identified a protein called tyrosine phosphatase 1B (PTP1B) as a potential "switch" that can modulate a type of cancer cell death known as immunogenic cell death (ICD).
Verticals
healthmedical
Originally published on Medical Xpress on 3/5/2026